| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |